OTHERS GENTING BERHAD ("GENT" OR "THE COMPANY") - GENT'S ASSOCIATE, TAURX PHARMACEUTICALS LTD., ANNOUNCED RESULTS FROM PHASE 3 ALZHEIMER'S DISEASE STUDY, LUCIDITY
GENTING BERHAD |
Type | Announcement |
Subject | OTHERS |
Description | GENTING BERHAD ("GENT" OR "THE COMPANY") - GENT'S ASSOCIATE, TAURX PHARMACEUTICALS LTD., ANNOUNCED RESULTS FROM PHASE 3 ALZHEIMER'S DISEASE STUDY, LUCIDITY |
Further to GENT's announcement dated 1 June 2022, the Company's associate, TauRx Pharmaceuticals Ltd., a leader in tau-based research in Alzheimer’s, had unveiled results from their Phase 3 Alzheimer’s study, LUCIDITY.
Please refer to the attached Press Release for further details.
This announcement is dated 6 October 2022. |
Please refer attachment below.
Announcement Info
Company Name | GENTING BERHAD |
Stock Name | GENTING |
Date Announced | 06 Oct 2022 |
Category | General Announcement for PLC |
Reference Number | GA1-06102022-00111 |